Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Spiegelman Daniel K
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   155,668    

Indirect Shares

   6,673      
Direct Value   $5,148,031    

Indirect Value

   $0      
Total Shares   162,341      
Total Value   $5,148,031      


CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $921,621 CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $921,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            CV Therapeutics Inc CVTX SVP, CFO 2009-04-09 67,489 2009-04-09 6,673    Premium*  
            Cascadian Therapeutics, Inc CASC Director 2018-03-09 0 2009-12-04 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Financial O... 2019-04-30 47,686 2012-05-29 0    Premium*  
            Relypsa Inc RLYP Director 2016-09-01 0 2015-06-04 0    Premium*  
            Myriad Genetics Inc MYGN Director 2023-06-02 40,493 2020-05-27 0    Premium*  
* Premium Members only  

Records found :    180         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-04-29 4 A $51.26 $10,355 D/D 202 64,135 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-10-31 5 A $51.26 $11,022 D/D 215 28,444 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2005-08-25 4 GD $0.00 $0 D/D 325 21,506 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2005-01-24 4 A $19.31 $6,488 I/I 336 1,860 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2006-12-22 4 GD $0.00 $0 D/D 400 11,386 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2017-06-12 4 D $3.34 $1,794 D/D (537) 12,432 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2017-09-24 4 D $3.94 $2,340 D/D (594) 21,006 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2008-05-29 5 GD $8.86 $5,272 D/D 595 18,576 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2016-06-06 5 D $7.38 $5,026 D/D (681) 10,821 0 -
CVTX CV Therapeutics Inc Senior Vice President and CFO   •       –      –    2004-01-13 4 A $14.67 $10,000 I/I 682 1,524 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-03-01 4 D $94.76 $86,421 D/D (912) 62,538 0 -
CVTX CV Therapeutics Inc Senior Vice President and CFO   •       –      –    2004-12-28 4 OE $9.00 $9,000 D/D 1,000 20,988 -
RLYP Relypsa Inc Director   –       •      –    2016-06-07 4 S $19.31 $19,562 D/D (1,013) 1,237 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2013-06-09 4 D $1.86 $2,111 D/D (1,135) 24,357 0 -
RLYP Relypsa Inc Director   –       •      –    2016-09-01 4 D $32.00 $39,584 D/D (1,237) 2,250 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-05-15 4 D $57.44 $71,283 D/D (1,241) 63,126 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2005-11-03 4 OE $9.00 $13,500 D/D 1,500 1,500 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2011-12-04 4 D $6.86 $10,606 D/D (1,546) 19,339 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-05-29 4 AS $126.15 $199,065 D/D (1,578) 35,624 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-03-02 4 D $79.86 $128,495 D/D (1,609) 68,520 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-06-05 4 AS $122.30 $201,669 D/D (1,649) 28,229 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-06-06 4 AS $89.14 $146,992 D/D (1,649) 46,944 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-06-04 4 D $92.07 $157,532 D/D (1,711) 61,070 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-05-15 4 D $122.78 $211,427 D/D (1,722) 77,644 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2016-05-13 4 D $82.71 $142,427 D/D (1,722) 62,413 0 -
  180  Records found
  1   2  3   4   5   6   7   8      
  Page 2 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us